FindTrial
Sign In

LACTOBACILLUS REUTERI REUTERIN AS A THERAPEUTIC AGENT IN INFANTILE COLIC A PROSPECTIVE STUDY.

LACTOBACILLUS REUTERI REUTERIN AS A THERAPEUTIC AGENT IN INFANTILE COLIC A PROSPECTIVE STUDY.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-004124-12-IT
Enrollment
Unknown
Registered
2007-07-03
Start date
2005-05-23
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT OF INFANTILE COLIC IN BREASTFED INFANTS OF AGE BETWEEN 21 AND 90 DAYS MedDRA version: 6.1 Level: SOC Classification code 10017947

Interventions

Pharmaceutical Form: Oral drops, emulsion INN or Proposed INN: Silicones CAS Number: 8050-91-5 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 40-

Sponsors

AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026